Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis - Wikidata - awgldk - TriplyDB

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

http://www.wikidata.org/entity/Q21144689

about

Neuropeptides in depression: role of VGF The role of the vgf gene and VGF-derived peptides in nutrition and metabolism Proteomics Research in Schizophrenia Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues Increased alpha-defensins as a blood marker for schizophrenia susceptibility CSF metabolic and proteomic profiles in patients prodromal for psychosis.Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach.Integration of biosensors and drug delivery technologies for early detection and chronic management of illness Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model.Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.The cerebral microvasculature in schizophrenia: a laser capture microdissection study.Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia DNA methylation-based forensic age prediction using artificial neural networks and next generation sequencing Lipidomics reveals a link between CYP1B1 and SCD1 in promoting obesity.Biomarkers in psychiatry: drawbacks and potential for misuse Profiles of VGF Peptides in the Rat Brain and Their Modulations after Phencyclidine Treatment.Behavioral abnormalities with disruption of brain structure in mice overexpressing VGF.Biomarker discovery in neurodegenerative diseases: a proteomic approach.The role of proteomics in depression research Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples.Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.Peptidome analysis of cerebrospinal fluid by LC-MALDI MS Neuropeptide precursor VGF is genetically associated with social anhedonia and underrepresented in the brain of major mental illness: its downregulation by DISC1.An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors.Mass spectrum analysis of serum biomarker proteins from patients with schizophrenia.Identification of biomarkers for radiation-induced acute intestinal symptoms (RIAISs) in cervical cancer patients by serum protein profiling.Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission.A novel blood-based biomarker for detection of autism spectrum disorders Two-Dimensional Differential Gel Electrophoresis to Identify Protein Biomarkers in Amniotic Fluid of Edwards Syndrome (Trisomy 18) Pregnancies.Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment Large-scale identification of endogenous secretory peptides using electron transfer dissociation mass spectrometry The extended granin family: structure, function, and biomedical implications The proteome of schizophrenia.Current state and future directions of neurochemical biomarkers for Alzheimer's disease.The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders Cerebrospinal fluid: identification of diagnostic markers for schizophrenia.Biomarkers of HIV-1 associated dementia: proteomic investigation of sera.NPAS3 Regulates Transcription and Expression of VGF: Implications for Neurogenesis and Psychiatric Disorders.The audacity of proteomics: a chance to overcome current challenges in schizophrenia research.Proteomic research in psychiatry.

P2860

Q24647788-E072F312-84DE-4A74-BFAD-1DC800BF3824 Q24657048-77B600FD-8D69-43ED-B812-0551E48C0268 Q26766821-9FFB2DBE-177C-4819-A6EE-A089A478406C Q28253419-802ECB08-2040-42A9-9D51-8413CD70CA04 Q28273093-A9356D3D-1306-47B7-8577-756F13295BDC Q28469277-CF37CC3E-AC3B-47DA-905B-48D2C9D2C5E5 Q30009461-732C5D9D-B608-4471-9F02-DEA5AB6D97A5 Q30451853-D87ECE6F-7829-4AAE-8587-3E1A9EB0C23C Q30479725-E29B79D9-7ACC-43CD-874D-8394A934F469 Q30801268-F8D771D8-58C9-4BB7-B302-C347BF3DD9AE Q33393640-7E9707AE-2022-4071-85A7-E43C215B0AFF Q33448981-3D4F1816-DA18-431A-87C9-6069F4C473F4 Q33567569-12FD6A9F-11E0-4B96-8B2D-4DA32BE6847F Q33598703-C00502DB-037F-4743-ADEF-3077FA5FBCEF Q33647114-7E0ACB1E-F9F3-4F69-A456-8321A50C1F68 Q33753194-60D7749F-2BE4-4374-9CBB-4BC2DE7A9926 Q33875986-9B1BE895-F824-4254-B94A-A322D010040E Q34125681-B233BD2D-48A9-45F4-BA1C-9A58F0A08211 Q34130553-229C45CB-B9D1-4603-BCF9-011E83B85A1B Q34194779-01DB14C7-BDD1-4EB7-9FD6-306EA3A924D5 Q34241223-120FA834-1132-47C6-8DB7-963C0C53A6F7 Q34374324-87721F53-F2AC-40D7-ABEE-CE1FE967D28D Q34378979-0471FAC9-9AEE-4DEA-97A7-A4F1E6B0BA4C Q34749242-A7AA97D1-759C-4C35-911B-77B83AB89835 Q35047339-983CFBA7-4B1A-4BC6-955D-F15FF2890BDB Q35277525-04F79C4C-BCF2-4BD9-9736-300F6C920C2E Q35598785-4D77F7EC-C6E6-46D8-B1DA-BF8AC4540152 Q35844268-91897A88-B01F-4707-B991-907F10435C33 Q35890658-339DEE72-22C2-4737-AC58-0B20326A1A80 Q36121837-446BDA85-74A1-4E12-AF37-4378AD9143DD Q36666362-F3915017-3B40-4143-82D0-0BBBCA42023E Q36666413-057D216F-8E8B-4E5D-A68D-174F290EC6D4 Q36848272-3FF6CBE5-CA10-48F2-A8A7-E307CC772447 Q36985933-1A86F248-7F28-411A-ADD9-83B582BB3055 Q37056209-35D6B0DC-8069-4C2D-AE67-1908B397ECE7 Q37118995-A58D63AD-36AB-4757-8E6F-AB772DCB4CA6 Q37152990-1B77D71C-5457-4D20-9A83-CF96EAAA629D Q37399106-9D429E5B-092C-4C54-ACF6-57DB1F1E516D Q37636121-F47E2F9C-D288-45E0-BA4C-4665FC660B6B Q37689362-7D7BE7A2-3986-4C83-8A35-853E3B608A8B

P2860

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

http://www.wikidata.org/entity/Q21144689

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@ast

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@en

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@en-gb

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@nl

type

label

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@ast

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@en

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@en-gb

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@nl

altLabel

Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset Psychosis

@en

prefLabel

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@ast

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@en

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@en-gb

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@nl

P1433

Q21144689-0E150F37-E05E-46C5-9094-04D86F978633

P1476

Q21144689-33B5C7F0-41AB-450F-94D1-C95561EA5258

P2093

Q21144689-146A73EC-1B83-47CD-9714-2E74B07302A9

Q21144689-1981C6D7-C60E-4A38-85C3-81A7B1E01A06

Q21144689-3ABE8982-5A07-466E-A0B8-EF17B43D714A

Q21144689-41B5E959-C47D-46FD-9218-A8A7BF7054AC

Q21144689-81D89C79-6BB7-4197-B912-59176C7BE73D

Q21144689-A6E18471-EA78-4E46-B6E0-311DE0BB6C9C

Q21144689-AECC0708-33A5-4C4C-9C3E-056B5C6EC8FD

Q21144689-C3764DB1-8AA0-416F-A39D-884B22ACAE2A

Q21144689-E3BEB925-4C2D-4902-9F29-1DB1E923DE5F

Q21144689-FD62E340-009A-4283-841F-2628749C9AA1

P2860

Q21144689-07C05C13-98D1-4360-89F5-61EB4E5CCCA9

Q21144689-0CA7744A-104C-4559-9562-07ADBE5DD8B6

Q21144689-100EA4A1-4403-4D3F-9939-26921AD7A950

Q21144689-1987C1D2-98E5-498F-AB04-DF925C2E7C0F

Q21144689-1FC05AF9-3B69-4240-8B3B-955CBDFD08A4

Q21144689-27EA0113-3AC3-4918-B6B0-7390372B0FD5

Q21144689-33AC592B-BE43-4D84-B0E7-72ED717874D3

Q21144689-58240A3E-51A2-4B3B-93C9-E5D0FA7EBF13

Q21144689-6BA05CE8-BC36-48D5-B556-A42DD5F9F7B2

Q21144689-800B3B20-84E5-4F21-94B1-6441B3E4A033

P304

Q21144689-8FFEA830-E3D5-4B4C-8372-3370CF66E822

P31

Q21144689-49B6F75A-F00B-410C-9DDA-1F2C996E37A1

P3181

Q21144689-C088A62F-2675-4875-BB82-600591B4D24C

P356

Q21144689-74291F5D-471F-476C-9D7F-B61573E1BB6C

P407

Q21144689-7D062FF4-4393-41B3-B205-C87C12CACCA5

P433

Q21144689-BC606C31-4DF1-4435-AC37-0D02C25E16AD

P478

Q21144689-86DE2972-438B-4D23-BB5B-8B7B911DD1FD

P50

Q21144689-0A937CB1-5719-4EAD-A9EC-D9FD80D67D40

Q21144689-2FC870EB-9052-4D20-A5E9-3E5D68E0F8E4

P577

Q21144689-8A9FEBCF-D043-4224-9109-224EBD6AA4E0

P5875

Q21144689-FDD61008-6D9F-4CF6-B3F5-9A285A388805

P698

Q21144689-332AB3D6-FBD2-4F25-92FB-E7463C77C4FA

P921

Q21144689-1D008AFD-33F8-40A9-A986-778188B4ECF7

Q21144689-40FC00B4-EBA4-4B26-B175-FF56E6141FFD

Q21144689-FB380244-94A9-4BB2-A760-BE2C7D95033C

Q21144689-FE75A082-594C-4C15-88A7-1F1F67624ED1

P932

Q21144689-89D8DF65-AA58-42DB-8B3E-FD5CBE03E27D

P3181

P356

JOURNAL.PMED.0030428

P1433

P1476

Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis

@en

P2093

Benjamin Reed

http://www.w3.org/2001/XMLSchema#string

Brit M Nolden

http://www.w3.org/2001/XMLSchema#string

Christoph W Gerth

http://www.w3.org/2001/XMLSchema#string

Daniela Schreiber

http://www.w3.org/2001/XMLSchema#string

David Oxley

http://www.w3.org/2001/XMLSchema#string

F Markus Leweke

http://www.w3.org/2001/XMLSchema#string

Jeffrey T-J Huang

http://www.w3.org/2001/XMLSchema#string

Lan Wang

http://www.w3.org/2001/XMLSchema#string

Nathan Harris

http://www.w3.org/2001/XMLSchema#string

Sonja Gross

http://www.w3.org/2001/XMLSchema#string

P2860

Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay

The genetics of schizophrenia

Current developments in SELDI affinity technology

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia

Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance

VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity

Pro-VGF-derived peptides induce penile erection in male rats: possible involvement of oxytocin

P304

e428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2625485

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0030428

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6707504

http://www.w3.org/2001/XMLSchema#string

P698

17090210

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

1630717

http://www.w3.org/2001/XMLSchema#string